Cite
Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
MLA
Kamitani, Naoki, et al. “Association of Skeletal Muscle Loss with the Long-Term Outcomes of Esophageal Cancer Patients Treated with Neoadjuvant Chemotherapy.” Surgery Today, vol. 49, no. 12, Dec. 2019, pp. 1022–28. EBSCOhost, https://doi.org/10.1007/s00595-019-01846-1.
APA
Kamitani, N., Migita, K., Matsumoto, S., Wakatsuki, K., Kunishige, T., Nakade, H., Miyao, S., & Sho, M. (2019). Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy. Surgery Today, 49(12), 1022–1028. https://doi.org/10.1007/s00595-019-01846-1
Chicago
Kamitani, Naoki, Kazuhiro Migita, Sohei Matsumoto, Kohei Wakatsuki, Tomohiro Kunishige, Hiroshi Nakade, Shintaro Miyao, and Masayuki Sho. 2019. “Association of Skeletal Muscle Loss with the Long-Term Outcomes of Esophageal Cancer Patients Treated with Neoadjuvant Chemotherapy.” Surgery Today 49 (12): 1022–28. doi:10.1007/s00595-019-01846-1.